Evans AH, Okai D, Weintraub D, Lim SY, O’Sullivan SS, Voon V et al (2019) Scales to assess impulsive and compulsive behaviors in Parkinson’s disease: critique and recommendations. Mov Disord 34(6):791–798. https://doi.org/10.1002/mds.27689

Article  PubMed  Google Scholar 

Weintraub D, David AS, Evans AH, Grant JE, Stacy M (2015) Clinical spectrum of impulse control disorders in Parkinson’s disease. Mov Disord 30(2):121–127. https://doi.org/10.1002/mds.26016

Article  PubMed  CAS  Google Scholar 

Marković V, Stanković I, Petrović I, Stojković T, Dragašević-Mišković N, Radovanović S et al (2020) Dynamics of impulsive-compulsive behaviors in early Parkinson’s disease: a prospective study. J Neurol 267(4):1127–1136. https://doi.org/10.1007/s00415-019-09692-4

Article  PubMed  Google Scholar 

Debove I, Paschen S, Amstutz D, Cardoso F, Corvol JC, Fung VSC et al (2024) Management of impulse control and related disorders in Parkinson’s disease: an expert consensus. Mov Disord 39(2):235–248. https://doi.org/10.1002/mds.29700

Article  PubMed  Google Scholar 

Corvol JC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P et al (2018) Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology 91(3):e189–e201. https://doi.org/10.1212/WNL.0000000000005816

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kraemmer J, Smith K, Weintraub D, Guillemot V, Nalls MA, Cormier-Dequaire F et al (2016) Clinical-genetic model predicts incident impulse control disorders in Parkinson’s disease. J Neurol Neurosurg Psychiatry 87(10):1106–1111. https://doi.org/10.1136/jnnp-2015-312848

Article  PubMed  Google Scholar 

Morgante F, Fasano A, Ginevrino M, Petrucci S, Ricciardi L, Bove F et al (2016) Impulsive-compulsive behaviors in parkin-associated Parkinson disease. Neurology 87(14):1436–1441. https://doi.org/10.1212/WNL.0000000000003177

Article  PubMed  PubMed Central  Google Scholar 

Amami P, De Santis T, Invernizzi F, Garavaglia B, Albanese A (2021) Impulse control behavior in GBA-mutated parkinsonian patients. J Neurol Sci 15(421):117291. https://doi.org/10.1016/j.jns.2020.117291

Article  CAS  Google Scholar 

Marković I, Kresojević N, Kostić VS (2016) Glucocerebrosidase and parkinsonism: lessons to learn. J Neurol 263(5):1033–1044. https://doi.org/10.1007/s00415-016-8085-4

Article  PubMed  CAS  Google Scholar 

Leocadi M, Canu E, Donzuso G, Stojkovic T, Basaia S, Kresojević N et al (2022) Longitudinal clinical, cognitive, and neuroanatomical changes over 5 years in GBA-positive Parkinson’s disease patients. J Neurol 269(3):1485–1500. https://doi.org/10.1007/s00415-021-10713-4

Article  PubMed  Google Scholar 

Beutler E, Gelbart T, Scott CR (2005) Hematologically important mutations: Gaucher disease. Blood Cells Mol Dis 35(3):355–364. https://doi.org/10.1016/j.bcmd.2005.07.005

Article  PubMed  CAS  Google Scholar 

Thaler A, Bregman N, Gurevich T, Shiner T, Dror Y, Zmira O et al (2018) Parkinson’s disease phenotype is influenced by the severity of the mutations in the GBA gene. Parkinsonism Relat Disord 55:45–49. https://doi.org/10.1016/j.parkreldis.2018.05.009

Article  PubMed  Google Scholar 

Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30(12):1591–1601. https://doi.org/10.1002/mds.26424

Article  PubMed  Google Scholar 

Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED et al (2009) Validation of the questionnaire for impulsive-compulsive disorders in Parkinson’s disease. Mov Disord 24(10):1461–1467. https://doi.org/10.1002/mds.22571

Article  PubMed  PubMed Central  Google Scholar 

Kumar KR, Ramirez A, Göbel A, Kresojević N, Svetel M, Lohmann K et al (2013) Glucocerebrosidase mutations in a Serbian Parkinson’s disease population. Eur J Neurol 20(2):402–405. https://doi.org/10.1111/j.1468-1331.2012.03817.x

Article  PubMed  CAS  Google Scholar 

Jankovic MZ, Dobricic V, Kresojevic N, Markovic V, Petrovic I, Svetel M et al (2018) Identification of mutations in the PRKN gene in Serbian patients with Parkinson’s disease. J Neurol Sci 393:27–30. https://doi.org/10.1016/j.jns.2018.07.020

Article  PubMed  CAS  Google Scholar 

Janković MZ, Kresojević ND, Dobričić VS, Marković VV, Petrović IN, Novaković IV et al (2015) Identification of novel variants in LRRK2 gene in patients with Parkinson’s disease in Serbian population. J Neurol Sci 353(1–2):59–62. https://doi.org/10.1016/j.jns.2015.04.002

Article  PubMed  CAS  Google Scholar 

Höglinger G, Schulte C, Jost WH, Storch A, Woitalla D, Krüger R et al (2022) GBA-associated PD: chances and obstacles for targeted treatment strategies. J Neural Transm 129(9):1219–1233. https://doi.org/10.1007/s00702-022-02511-7

Article  PubMed  Google Scholar 

Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V et al (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67(5):589–595. https://doi.org/10.1001/archneurol.2010.65

Article  PubMed  Google Scholar 

Weiss HD, Marsh L (2012) Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson disease. Neurol Clin Pract 2(4):267–274. https://doi.org/10.1212/CPJ.0b013e318278be9b

Article  PubMed  PubMed Central  Google Scholar 

Simuni T, Brumm MC, Uribe L, Caspell-Garcia C, Coffey CS, Siderowf A et al (2020) Clinical and dopamine transporter imaging characteristics of leucine rich repeat kinase 2 (LRRK2) and glucosylceramidase beta (GBA) Parkinson’s disease participants in the Parkinson’s progression markers initiative: a cross‐sectional study. Mov Disord 35(5):833–844. https://doi.org/10.1002/mds.27989

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jesús S, Huertas I, Bernal-Bernal I, Bonilla-Toribio M, Cáceres-Redondo MT, Vargas-González LI et al (2016) GBA variants influence motor and non-motor features of Parkinson’s disease. PLoS One 11(12):e0167749

PubMed  PubMed Central  Google Scholar 

De Michele G, Palmieri GR, Pane C, Valente EM, Palmieri I, Dello Iacovo CDP et al (2023) Motor and non-motor features in Parkinson’s disease patients carrying GBA gene mutations. Acta Neurol Belg 123(1):221–226. https://doi.org/10.1007/s13760-022-02165-y

Article  PubMed  Google Scholar 

Vieira SRL, Schapira AHV (2022) Glucocerebrosidase mutations and Parkinson disease. J Neural Transm 129(9):1105–1117. https://doi.org/10.1007/s00702-022-02531-3

Article  PubMed  Google Scholar 

Kresojević N, Marković V, Dobričić V, Stanković I, Stojković T, Tomić A et al (2023) Reply to: “differences in sex-specific frequency of glucocerebrosidase variant carriers and familial Parkinsonism.” Mov Disord 38(4):712–713. https://doi.org/10.1002/mds.29351

Article  PubMed  CAS  Google Scholar 

Amami P, De Santis T, Garavaglia B, Albanese A (2020) Impulsive control behaviours in patients with GBA, PRKN and without mutations in genes associated to Parkinson disease. Parkinsonism Relat Disord 79:e20–e21. https://doi.org/10.1016/j.parkreldis.2020.06.098

Article  Google Scholar 

Avenali M, Zangaglia R, Cuconato G, Palmieri I, Albanese A, Artusi CA et al (2024) Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort. J Neurol Neurosurg Psychiatry 95(4):309–315. https://doi.org/10.1136/jnnp-2023-332387

Article  PubMed  Google Scholar 

Ortega RA, Bressman SB, Raymond D, Ozelius LJ, Katsnelson V, Leaver K et al (2022) Differences in sex-specific frequency of glucocerebrosidase variant carriers and familial Parkinsonism. Mov Disord 37(11):2217–2225. https://doi.org/10.1002/mds.29197

Article  PubMed  PubMed Central  CAS  Google Scholar 

Thaler A, Mirelman A, Alcalay RN (2023) Differences in sex-specific frequency of glucocerebrosidase variant carriers and familial Parkinsonism. Mov Disord 38(4):713–714. https://doi.org/10.1002/mds.29348

Article  PubMed